MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
If you are interested in MPLN stock information, you might also be interested in competitors like NasdaqGS:CNDT.
With a P/E ratio of , the stock appears relatively cheap compared to its index ^R3GPREOD at the moment.
The market capitalization of MultiPlan is currently at $1.88 B. This places it among the low capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 0.8.
With one share of MultiPlan investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.
For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.94. The price of the stock NYSE:MPLN is therefore subject to moderate fluctuations in relation to the overall market.
66.3% of MPLN Stocks is owned by insiders.
Since not enough Wall Street analysts have published their estimates, we are unfortunately unable to provide a reliable price target for the MPLN stock.
NYSE:MPLN has a 52 week range of $3.25 - $9.69 and is currently trading around $2.94.
The low short sale ratio indicated that the value might increase in the foreseeable future.